Clinical Trials Browser

Observational × Fulvestrant × Clear all

NCT05022342 2026-02-23

SPEAR

Breast Neoplasms

NCT07347600 2026-02-20

reaINAVO

Breast Neoplasms

NCT04967248 2025-12-04

A NIS of Alpelisib in Combination With Fulvestrant in Postmenopausal Women, and Men, With HR+,HER2- , Locally Advanced or Metastatic Breast Cancer With a PIK3CA Mutation, After Disease Progression Following Endocrine Therapy as Monotherapy, in the Real-world Setting

Breast Neoplasms

NCT07096024 2025-08-28

A Study to Understand About the Study Medicine Palbociclib in Breast Cancer Patients After it is Out in the Japanese Market

Breast Neoplasms

NCT06734533 2024-12-16

Anlotinib-based Combination Therapy in Patients with Hormone Receptor-positive（HR+） Metastatic Breast Cancer(MBC) .

HR+ Breast Cancer

NCT06525675 2024-12-13

Study to Evaluate the Extended Overall Survival (OS) Data From PARSIFAL Study (The PARSIFAL-LONG Study)

Breast Neoplasms

NCT06341283 2024-05-10

A Retrospective Real-world Study of Abemaciclib in HR+ Breast Cancer

Not yet recruiting

Breast Diseases, Breast Neoplasms, Neoplasms

NCT04916509 2023-06-06

Treatment Patterns and Clinical Outcomes Among Patients Receiving Palbociclib Combinations for Hormone Receptor Positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2 ) Advanced/Metastatic Breast Cancer in the Arabian Gulf Region

Breast Neoplasms

NCT02753686 2023-02-15

Treat ER+ight

Neoplasm Metastasis, Multiple Endocrine Neoplasia Type 1

NCT05427617 2022-06-22

ACTDNAGLT

Breast Neoplasms

NCT02909361 2022-04-20

Fulvestrant 500mg in Patients With Advanced Breast Cancer

Breast Neoplasms

NCT05140655 2021-12-01

Effectiveness and Safety of Fulvestrant in Postmenopausal Women With Advanced Breast Cancer HR+, HER2-

Breast Neoplasm Female

NCT04852081 2021-04-21

Analysis of Therapy Sequence in Women With HR+, HER2 - mBC in Moscow: A Multicenter Retrospective Observational Study.

Breast Neoplasms

NCT04524728 2020-08-24

Patterns of Treatment and Outcome of Palbociclib Plus Endocrine Therapy

Breast Neoplasms, Neoplasms

NCT04289974 2020-02-28

Predicted Biomarkers of CDK4/6 Inhibitors (Palbociclib) in ER-positive Metastasis Breast Cancer

Breast Neoplasms

NCT04258163 2020-02-10

Association of Survival With Maintenance Therapy in Patients With Metastatic Breast Cancer After First-line Chemotherapy

Breast Neoplasms

NCT03925233 2019-04-24

Breast Cancer Treatment Based on Organ-like Culture

Breast Cancer Organoids

NCT01399086 2012-03-13

Fulvestrant in Postmenopausal Patients With Metastatic Breast Cancer

Breast Neoplasms, Neoplasm Metastasis, Neoplasms

NCT00660803 2010-01-21

Retrospective Brazilian Study of Fulvestrant in Advanced Breast Cancer

Breast Neoplasms